ArticleA Study of the Protective Role Versus the Curative Role of Pentoxifylline on Experimentally Induced Diabetic Nephropathy in a Rat Model
ArticleA Study of the Protective Role Versus the Curative Role of Pentoxifylline on Experimentally Induced Diabetic Nephropathy in a Rat Model
ArticleExperimental Rat Model of Diabetic Nephropathy: RAGE Detection and Effect of Spironolactone Monotherapy
ArticleExperimental Rat Model of Diabetic Nephropathy: RAGE Detection and Effect of Spironolactone Monotherapy
ArticleAmeliorative effect of Metformin Nano emulsion against induced diabetic nephropathy in rat model: microanatomy study
ArticleAmeliorative effect of Metformin Nano emulsion against induced diabetic nephropathy in rat model: microanatomy study
ArticleThe Ameliorative Effect of Proanthocyanidinsagainst Streptozotocin Induced Diabetic Nephropathy in Rats
ArticleThe Ameliorative Effect of Proanthocyanidinsagainst Streptozotocin Induced Diabetic Nephropathy in Rats
ArticleMaresin-1 mitigates streptozotocin induced diabetic nephropathy in rats via up-regulation of Nrf2/HO-1 pathway
ArticleMaresin-1 mitigates streptozotocin induced diabetic nephropathy in rats via up-regulation of Nrf2/HO-1 pathway
ArticleCOMPARATIVE GLUCOSE-LOWERING AND RENOPROTECTIVE EFFECTS OF SITAGLIPTIN AND INSULIN AND THEIR COMBINED THERAPY ON TYPE-2 DIABETES MELLITUS WITH NEPHROPATHY IN RATS
ArticleCOMPARATIVE GLUCOSE-LOWERING AND RENOPROTECTIVE EFFECTS OF SITAGLIPTIN AND INSULIN AND THEIR COMBINED THERAPY ON TYPE-2 DIABETES MELLITUS WITH NEPHROPATHY IN RATS
ArticleTHE POTENTIAL MODULATING IMPACT OF THE DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITOR, SITAGLIPTIN ON STREPTOZOTOCIN-NICOTINAMIDE-INDUCED DIABETIC NEPHROPATHY IN RATS
ArticleTHE POTENTIAL MODULATING IMPACT OF THE DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITOR, SITAGLIPTIN ON STREPTOZOTOCIN-NICOTINAMIDE-INDUCED DIABETIC NEPHROPATHY IN RATS
ArticleMetrnl impact in streptozotocin induced diabetic nephropathy in rats, targeting Nrf2/HO-1 pathway
ArticleMetrnl impact in streptozotocin induced diabetic nephropathy in rats, targeting Nrf2/HO-1 pathway